Why the study?
Does statin therapy reduce major adverse cardiovascular events in acute coronary syndrome patients with baseline LDL-cholesterol < 70 mg/dL?
Population
3,374 acute coronary syndromes patients who were discharged alive and had baseline LDL-cholesterol levels…
Comparison
Statin therapy prescribed at discharge vs No statin therapy prescribed at discharge
Design
Cohort
Follow-up
12 months
Authors
Loading...
Statin use at discharge was associated with lower MACE risk; hypothesis-generating in low-LDL ACS and requires RCT confirmation.
Does statin therapy reduce major adverse cardiovascular events in acute coronary syndrome patients with baseline LDL-cholesterol < 70 mg/dL?
Statin therapy at discharge is associated with a significantly lower risk of 1-year MACE and mortality in ACS patients even when baseline LDL-C is already below 70 mg/dL.
Sun et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: